Global Intrauterine Contraceptive Devices Market Research Report
Intrauterine Contraceptive Devices and its peer markets - Ear, Nose & Throat Devices, Mobility Aid Devices , Feeding Device(Nutrition), Diagnostic Imaging, Nephrology/Urology Devices, Dermatology Devices, Cardiology Devices, Point of Care Testing, General & Plastic Surgery and 20 other markets - adds up to total Medical Devices market.
Intrauterine Contraceptive Devices can be segmented by Technologies and Usages. Technologies of this market are Copper IUD, Hormone-releasing IUD and Inert IUD. Usages of this market are Short Term, Mid Term and Long Term.
Key Questions Answered
What are market estimates and forecasts; which of Intrauterine Contraceptive Devices markets are doing well and which are not?
What makes our report unique?
This report provides market sizing and forecast for the Intrauterine Contraceptive Devices market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
Intrauterine Contraceptive Devices can be segmented by Technologies and Usages. Technologies of this market are Copper IUD, Hormone-releasing IUD and Inert IUD. Usages of this market are Short Term, Mid Term and Long Term.
Key Questions Answered
What are market estimates and forecasts; which of Intrauterine Contraceptive Devices markets are doing well and which are not?
What makes our report unique?
This report provides market sizing and forecast for the Intrauterine Contraceptive Devices market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
- Audience for this report
- Global Intrauterine Contraceptive Devices companies
- Manufacturing Companies
- Traders, distributors, and suppliers
- Governmental and research organizations
- Associations and industry bodies
- Technology providers
1 EXECUTIVE SUMMARY
1.1 INTRODUCTION
1.2 OBJECTIVES OF THE STUDY
1.3 MARKET DEFINITION AND SCOPE OF THE STUDY
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.1.1 Top-Down Approach
1.4.2 MARKET SHARE
1.5 ASSUMPTIONS
2 MARKET OVERVIEW
2.1 MARKET SEGMENTATION
3 MARKET DYNAMICS
3.1 MARKET DRIVERS
3.1.1 INCREASING RATE OF UNPLANNED PREGNANCIES
3.1.2 EFFECTIVE CONTRACEPTION AND FEWER SIDE EFFECTS
3.1.3 IMPLEMENTATION OF AFFORDABLE CARE ACT IN THE U.S.
3.1.4 RISING NUMBER OF PRIVATE FIRMS’ INITIATIVES DIRECTED TOWARDS CURBING UNINTENDED PREGNANCY AND ABORTION-RELATED EXPENSES
3.1.5 INCREASE IN FUNDS AND GRANTS FOR IUCDs
3.1.6 TECHNOLOGICAL ADVANCEMENTS
3.2 MARKET RESTRAINTS
3.2.1 HIGH COST OF TREATMENT
3.2.2 THREAT OF PELVIC INFLAMMATORY DISEASES
3.2.3 THREAT OF ECTOPIC PREGNANCY
3.2.4 HIGH RATE OF COMPLICATIONS DURING UNPLANNED PREGNANCIES
3.2.5 COMPULSORY ASSISTANCE OF HEALTHCARE PROFESSIONALS
4 INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY TYPE
4.1 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES, BY TYPE
4.2 UNITED STATES INTRAUTERINE CONTRACEPTIVE DEVICES, BY TYPE
4.3 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES, BY TYPES
5 COMPETITIVE LANDSCAPE
5.1 INTRODUCTION
5.2 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE (%), BY COMPANY
5.3 CANADIAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE (%) , BY COMPANY
5.4 COMPANY DEVELOPMENTS
6 COMPANY PROFILES
6.1 BAYER HEALTHCARE AG (A SUBSIDIARY OF BAYER AG)
6.1.1 Overview
6.1.2 Product Portfolio
6.1.3 Financials
6.1.4 Recent Developments
6.1.5 SWOT Analysis:
6.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.2.1 Overview
6.2.2 Product Portfolio
6.2.3 Financials
6.2.4 Recent Developments
6.2.5 SWOT ANALYSIS:
6.3 ACTAVIS PLC
6.3.1 Overview
6.3.2 Product Portfolio
6.3.3 Financials
6.3.4 Recent developments
6.4 MEDICINES360
6.4.1 Overview
6.4.2 Product Portfolio
6.4.3 Financials
6.4.4 Recent Developments
6.5 TRIMEDIC SUPPLY NETWORK LTD.
6.5.1 Overview
6.5.2 Products
6.5.3 Financials
6.6 MEDISAFE DISTRIBUTION INC.
6.6.1 Overview
6.6.2 Product Portfolio
6.6.3 Financials
6.7 PACE PHARMACEUTICALS, INC.
6.7.1 Overview
6.7.2 Products
6.7.3 Financials
1.1 INTRODUCTION
1.2 OBJECTIVES OF THE STUDY
1.3 MARKET DEFINITION AND SCOPE OF THE STUDY
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.1.1 Top-Down Approach
1.4.2 MARKET SHARE
1.5 ASSUMPTIONS
2 MARKET OVERVIEW
2.1 MARKET SEGMENTATION
3 MARKET DYNAMICS
3.1 MARKET DRIVERS
3.1.1 INCREASING RATE OF UNPLANNED PREGNANCIES
3.1.2 EFFECTIVE CONTRACEPTION AND FEWER SIDE EFFECTS
3.1.3 IMPLEMENTATION OF AFFORDABLE CARE ACT IN THE U.S.
3.1.4 RISING NUMBER OF PRIVATE FIRMS’ INITIATIVES DIRECTED TOWARDS CURBING UNINTENDED PREGNANCY AND ABORTION-RELATED EXPENSES
3.1.5 INCREASE IN FUNDS AND GRANTS FOR IUCDs
3.1.6 TECHNOLOGICAL ADVANCEMENTS
3.2 MARKET RESTRAINTS
3.2.1 HIGH COST OF TREATMENT
3.2.2 THREAT OF PELVIC INFLAMMATORY DISEASES
3.2.3 THREAT OF ECTOPIC PREGNANCY
3.2.4 HIGH RATE OF COMPLICATIONS DURING UNPLANNED PREGNANCIES
3.2.5 COMPULSORY ASSISTANCE OF HEALTHCARE PROFESSIONALS
4 INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY TYPE
4.1 NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES, BY TYPE
4.2 UNITED STATES INTRAUTERINE CONTRACEPTIVE DEVICES, BY TYPE
4.3 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES, BY TYPES
5 COMPETITIVE LANDSCAPE
5.1 INTRODUCTION
5.2 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE (%), BY COMPANY
5.3 CANADIAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE (%) , BY COMPANY
5.4 COMPANY DEVELOPMENTS
6 COMPANY PROFILES
6.1 BAYER HEALTHCARE AG (A SUBSIDIARY OF BAYER AG)
6.1.1 Overview
6.1.2 Product Portfolio
6.1.3 Financials
6.1.4 Recent Developments
6.1.5 SWOT Analysis:
6.2 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.2.1 Overview
6.2.2 Product Portfolio
6.2.3 Financials
6.2.4 Recent Developments
6.2.5 SWOT ANALYSIS:
6.3 ACTAVIS PLC
6.3.1 Overview
6.3.2 Product Portfolio
6.3.3 Financials
6.3.4 Recent developments
6.4 MEDICINES360
6.4.1 Overview
6.4.2 Product Portfolio
6.4.3 Financials
6.4.4 Recent Developments
6.5 TRIMEDIC SUPPLY NETWORK LTD.
6.5.1 Overview
6.5.2 Products
6.5.3 Financials
6.6 MEDISAFE DISTRIBUTION INC.
6.6.1 Overview
6.6.2 Product Portfolio
6.6.3 Financials
6.7 PACE PHARMACEUTICALS, INC.
6.7.1 Overview
6.7.2 Products
6.7.3 Financials
LIST OF TABLES
Table 1 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY COUNTRY, 2012–2019 (USD MILLION)
Table 2 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY TYPE, 2012–2019 (USD MILLION)
Table 3 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET (IUCD), BY TYPE, 2012 – 2019 (USD MILLION)
Table 4 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MILLION)
Table 1 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY COUNTRY, 2012–2019 (USD MILLION)
Table 2 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY TYPE, 2012–2019 (USD MILLION)
Table 3 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES MARKET (IUCD), BY TYPE, 2012 – 2019 (USD MILLION)
Table 4 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MILLION)
LIST OF FIGURES
Figure 1 PERCENTAGE OF VARIOUS CONTRACEPTIVE PROCEDURES, GLOBAL, 2012-2013
Figure 2 MARKET SIZE ESTIMATION METHODOLOGY, TOP-DOWN APPROACH
Figure 3 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD), MARKET SEGMENTATION
Figure 4 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE, BY COUNTRY, 2013
Figure 5 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE, BY TYPE, 2013
Figure 6 PERCENTAGE USAGE OF VARIOUS CONTRACEPTIVE DEVICES METHODS, U.S., 2012 – 2013
Figure 7 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY TYPE, 2013
Figure 8 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2013
Figure 9 U.S. IUCD MARKET SHARE (%), BY COMPANY, 2013
Figure 10 CANADA, IUCD MARKET SHARE (%), BY COMPANY, 2013
Figure 1 PERCENTAGE OF VARIOUS CONTRACEPTIVE PROCEDURES, GLOBAL, 2012-2013
Figure 2 MARKET SIZE ESTIMATION METHODOLOGY, TOP-DOWN APPROACH
Figure 3 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD), MARKET SEGMENTATION
Figure 4 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE, BY COUNTRY, 2013
Figure 5 NORTH AMERICAN INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SHARE, BY TYPE, 2013
Figure 6 PERCENTAGE USAGE OF VARIOUS CONTRACEPTIVE DEVICES METHODS, U.S., 2012 – 2013
Figure 7 U.S. INTRAUTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY TYPE, 2013
Figure 8 CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2013
Figure 9 U.S. IUCD MARKET SHARE (%), BY COMPANY, 2013
Figure 10 CANADA, IUCD MARKET SHARE (%), BY COMPANY, 2013
